Aradhana Sarin
President en ACHILLION PHARMACEUTICALS, INC. .
Fortuna: 11 M $ al 31/03/2024
Perfil
La Dra. Aradhana Sarin es presidenta y directora de Achillion Pharmaceuticals, Inc. y directora financiera y vicepresidenta ejecutiva de Alexion Pharmaceuticals, Inc. Forma parte del Consejo de Administración de Achillion Pharmaceuticals, Inc. El Dr. Sarin fue anteriormente director independiente de OraSure Technologies, Inc., director de banca corporativa y de inversión de Citizens, Inc. (Austin, Texas), y director general de banca de inversión en el sector sanitario en UBS AG. Obtuvo un MBA en la Stanford Graduate School of Business.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
ASTRAZENECA PLC
0.01% | 31/12/2023 | 82 514 ( 0.01% ) | 11 M $ | 31/03/2024 |
Últimas noticias acerca de Aradhana Sarin
Cargos activos de Aradhana Sarin
| Empresas | Cargo | Inicio |
|---|---|---|
| ACHILLION PHARMACEUTICALS, INC. | President | 28/01/2020 |
| ASTRAZENECA PLC | Director of Finance/CFO | 01/08/2021 |
| ANHEUSER-BUSCH INBEV SA/NV | Director/Board Member | 26/04/2023 |
Antiguos cargos conocidos de Aradhana Sarin.
| Empresas | Cargo | Fin |
|---|---|---|
| CITIZENS, INC. | Corporate Officer/Principal | 01/10/2017 |
| UBS | Corporate Officer/Principal | - |
| ALEXION PHARMACEUTICALS, INC. | Director of Finance/CFO | - |
| ORASURE TECHNOLOGIES, INC. | Director/Board Member | - |
Formación de Aradhana Sarin.
| University of Delhi | Doctorate Degree |
| Stanford Graduate School of Business | Masters Business Admin |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 4 |
|---|---|
| CITIZENS, INC. | Finance |
| ASTRAZENECA PLC | Health Technology |
| ORASURE TECHNOLOGIES, INC. | Health Technology |
| ANHEUSER-BUSCH INBEV SA/NV | Consumer Non-Durables |
| Empresas privadas | 3 |
|---|---|
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
UBS AG
 UBS AG Investment ManagersFinance UBS AG engages in the provision of financial advisory solutions for private and institutional investors, intermediaries, and wealth management clients. The firm focuses on the areas of wealth and asset management, as well as investment banking. It offers retail investment products, global financing services, investment research, bespoke financing, traditional investments, as well as bonds and equities. The company was founded in 1862 and is headquartered in Zurich, Switzerland. | Finance |
Achillion Pharmaceuticals, Inc.
 Achillion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Achillion Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of oral small molecule complement system inhibitors. Its pipeline includes Danicopan and ACH-5228. The company was founded on August 17, 1998 and is headquartered in Blue Bell, PA. | Health Technology |
- Bolsa de valores
- Insiders
- Aradhana Sarin
